Carcinoma of prostate: response of plasma luteinizing hormone and testosterone to oestrogen therapy.
作者信息
Alder A, Burger H, Davis J, Dulmanis A, Hudson B, Sarfaty G, Straffon W
出版信息
Br Med J. 1968 Jan 6;1(5583):28-30. doi: 10.1136/bmj.1.5583.28.
Abstract
摘要
相似文献
1
Carcinoma of prostate: response of plasma luteinizing hormone and testosterone to oestrogen therapy.前列腺癌：血浆促黄体生成素和睾酮对雌激素治疗的反应。
Br Med J. 1968 Jan 6;1(5583):28-30. doi: 10.1136/bmj.1.5583.28.
2
Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens.
Eur J Cancer (1965). 1974 Jul;10(7):445-9. doi: 10.1016/0014-2964(74)90028-0.
3
Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation.雌激素预处理可消除促黄体生成素释放激素对睾酮的刺激作用。
Br J Urol. 1988 Oct;62(4):352-4. doi: 10.1111/j.1464-410x.1988.tb04364.x.
4
Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine.
Br J Urol. 1985 Oct;57(5):542-7. doi: 10.1111/j.1464-410x.1985.tb05863.x.
5
Endocrine effects of oestrogen treatment in patients with prostatic cancer.雌激素治疗对前列腺癌患者的内分泌影响。
Eur Urol. 1976;2(2):85-8. doi: 10.1159/000471968.
6
Changes in plasma levels of FSH, LH and testosterone during anti-androgenic hormone therapy for patients with prostatic cancer.前列腺癌患者抗雄激素激素治疗期间血浆促卵泡生成素、促黄体生成素和睾酮水平的变化。
Tohoku J Exp Med. 1974 Oct;114(2):145-58. doi: 10.1620/tjem.114.145.
7
Endocrine changes after diethylstilbestrol therapy. Effects on prostatic neoplasm and pituitary-gonadal axis.
Urology. 1976 Feb;7(2):148-55. doi: 10.1016/0090-4295(76)90301-0.
8
Effects of synthetic oral oestrogens in normal men and patients with prostatic carcinoma: lack of gonadotrophin suppression by chlorotrianisene.
Clin Endocrinol (Oxf). 1973 Oct;2(4):297-306. doi: 10.1111/j.1365-2265.1973.tb01715.x.
9
Plasma testosterone in patients receiving diethylstilbestrol.
Urology. 1978 Feb;11(2):157-60. doi: 10.1016/0090-4295(78)90096-1.
10
[Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer].[土瑞烯酮对前列腺癌患者游离、生物活性睾酮水平的抑制作用]
Z Urol Nephrol. 1987 Mar;80(3):135-8.
引用本文的文献
1
Use of Systemic Glucocorticoids and Risk of Prostate Adenocarcinoma: Evidence From a Danish Population-Based Case-Control Study.全身糖皮质激素的使用与前列腺腺癌风险：来自丹麦一项基于人群的病例对照研究的证据。
Cancer Med. 2025 Aug;14(15):e71110. doi: 10.1002/cam4.71110.
2
Glucocorticoids and prostate cancer treatment: friend or foe?糖皮质激素与前列腺癌治疗：敌是友非？
Asian J Androl. 2014 May-Jun;16(3):354-8. doi: 10.4103/1008-682X.125392.
3
Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.雌激素化合物对雄激素非依赖性前列腺癌的抑制作用与免疫相关基因表达增加有关。
Neoplasia. 2006 Oct;8(10):862-78. doi: 10.1593/neo.06328.
4
The inhibition of deoxyribonucleic acid nucleotidyltransferase by stilboestrol derivatives.己烯雌酚衍生物对脱氧核糖核酸核苷酸转移酶的抑制作用。
Biochem J. 1968 Aug;108(5):749-53. doi: 10.1042/bj1080749.
5
Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma.
Br Med J. 1971 Nov 13;4(5784):391-4. doi: 10.1136/bmj.4.5784.391.
6
Control of hormonal treatment of carcinoma of the prostate.前列腺癌激素治疗的控制
Urol Res. 1973 Oct;1(3):120-1. doi: 10.1007/BF00257374.
7
High-dose diethylstilbestrol diphosphate therapy of prostatic cancer after failure of standard doses of estrogens.标准剂量雌激素治疗失败后前列腺癌的大剂量己烯雌酚二磷酸酯治疗
Can Med Assoc J. 1973 Oct 20;109(8):697-9.
8
Five-year clinical follow-up of prostatic cancer patients treated with fosfestrol and bromocriptine.用己烯雌酚磷酸酯和溴隐亭治疗的前列腺癌患者的五年临床随访
Int Urol Nephrol. 1987;19(1):81-5. doi: 10.1007/BF02549682.
本文引用的文献
1
A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma.一种用于测定人血浆中游离11-羟基皮质类固醇的简易荧光法。
J Clin Pathol. 1962 Jul;15(4):374-9. doi: 10.1136/jcp.15.4.374.
2
Carcinoma of the prostate: a clinical and steroid metabolic study.前列腺癌：一项临床与类固醇代谢研究。
Acta Chir Scand. 1955 Jun 18;109(2):129-49.
3
THE EFFECT OF DIETHYLSTILBOESTROL ON TESTICULAR 17ALPHA-HYDROXYLASE AND 17-DESMOLASE ACTIVITIES IN BALB/C MICE.己烯雌酚对BALB/C小鼠睾丸17α-羟化酶和17-碳链裂解酶活性的影响
Acta Endocrinol (Copenh). 1964 Apr;45:487-97. doi: 10.1530/acta.0.0450487.
4
IMMUNOASSAY OF HUMAN GROWTH HORMONE IN PLASMA.血浆中人生长激素的免疫测定
Nature. 1963 Aug 24;199:784-7. doi: 10.1038/199784a0.
5
The estimation of testosterone in biological fluids. 1. Testosterone in plasma.生物体液中睾酮的测定。1. 血浆中的睾酮。
Aust J Exp Biol Med Sci. 1963 Jun;41:235-46. doi: 10.1038/icb.1963.23.
6
Hormone therapy in prostatic cancer.前列腺癌的激素治疗
Am J Med. 1956 Nov;21(5):697-713. doi: 10.1016/0002-9343(56)90086-9.
7
Radioimmunoassay for human luteinizing hormone.人促黄体生成素放射免疫测定法
Metabolism. 1966 Apr;15(4):287-9. doi: 10.1016/0026-0495(66)90142-9.
8
Effect of ethinyloestradiol on plasma testosterone levels and urinary testosterone excretion in man.炔雌醇对男性血浆睾酮水平及尿睾酮排泄的影响。
Acta Endocrinol (Copenh). 1965 Sep;50(1):51-4. doi: 10.1530/acta.0.0500051.
9
Testosterone in human plasma.人血浆中的睾酮
N Engl J Med. 1965 Oct 21;273(17):902-7. doi: 10.1056/NEJM196510212731704.
Zotero 插件